Home
/
Coeptis Therapeutics Holdings, Inc.
/
Financials
/
Quarterly
Coeptis Therapeutics Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Coeptis Therapeutics Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$237.4K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$200.7K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$62.9K
May 14, 2025
Q3
2025
Sep 30, 2024
$0
Nov 14, 2025
Q2
2025
Jun 30, 2024
$0
Aug 14, 2025
Q1
2025
Mar 31, 2024
$0
May 14, 2025
Q3
2024
Sep 30, 2023
$0
Nov 13, 2024
Q2
2024
Jun 30, 2023
$0
Aug 16, 2024
Q1
2024
Mar 31, 2023
$0
Aug 16, 2024
Q3
2023
Sep 30, 2022
$0
Aug 16, 2024
Q2
2023
Jun 30, 2022
$0
Mar 25, 2024
Q1
2023
Mar 31, 2022
$0
Mar 25, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.90M)
Nov 14, 2025
Q3
2025
Jun 30, 2025
($4.33M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.33M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.42M)
May 14, 2025
Q3
2025
Mar 31, 2025
($3.42M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($3.42M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($1.83M)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($3.04M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($3.04M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.00M)
May 14, 2025
Q2
2025
Mar 31, 2024
($3.00M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($3.00M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($6.35M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($3.20M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.20M)
Aug 16, 2024
Q3
2024
Mar 31, 2023
($7.96M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($7.96M)
Aug 16, 2024
Q2
2024
Mar 31, 2023
($7.96M)
Aug 16, 2024
Q3
2023
Sep 30, 2022
($5.65M)
Aug 16, 2024
Q3
2023
Jun 30, 2022
($9.80M)
Aug 16, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.48M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.52M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($4.06M)
May 14, 2025
Q3
2025
Sep 30, 2024
($2.14M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.83M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.92M)
May 14, 2025
Q3
2024
Sep 30, 2023
($7.90M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.68M)
Aug 16, 2024
Q1
2024
Mar 31, 2023
($6.54M)
Aug 16, 2024
Q3
2023
Sep 30, 2022
($5.57M)
Aug 16, 2024
Q2
2023
Jun 30, 2022
($9.81M)
Mar 25, 2024
Q1
2023
Mar 31, 2022
($15.72M)
Mar 25, 2024
Q3
2022
Sep 30, 2021
($100.0K)
Nov 18, 2022
Q2
2022
Jun 30, 2021
($155.7K)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($141.5K)
May 10, 2022
Q3
2021
Sep 30, 2020
($50)
Nov 16, 2021
Q2
2021
Jun 30, 2020
($450)
Sep 14, 2021
Q3
2020
Sep 30, 2019
($1.0K)
Dec 10, 2020